HBV-IN-4 is a potent, orally bioavailable phthalazinone derivative that inhibits HBV replication with an IC50 of 14 nM by promoting the assembly of genome-free capsids. This mechanism supports its investigation in both cellular and animal models of hepatitis B infection.
Molecular Weight:
479.89
CAS Number:
[2305897-84-9]
Formula:
C24H19ClFN5O3
Target:
HBV,DNA/RNA Synthesis,Others
* VAT and and shipping costs not included. Errors and price changes excepted